Glipizide (Glipizide)


Indications and Reactions:

Role Indications Reactions
Secondary
Type 2 Diabetes Mellitus 45.2%
Product Used For Unknown Indication 26.2%
Diabetes Mellitus 19.0%
Blood Pressure 2.4%
Myelodysplastic Syndrome 2.4%
Skin Cancer 2.4%
Supplementation Therapy 2.4%
Blood Glucose Increased 16.7%
Nausea 16.7%
Tremor 11.1%
Anxiety Disorder 5.6%
Blood Glucose Decreased 5.6%
Diarrhoea 5.6%
Dizziness 5.6%
Incorrect Dose Administered 5.6%
Off Label Use 5.6%
Prostate Cancer 5.6%
Visual Impairment 5.6%
Vomiting 5.6%
Weight Decreased 5.6%
Concomitant
Type 2 Diabetes Mellitus 35.4%
Plasma Cell Myeloma 15.8%
Product Used For Unknown Indication 12.0%
Chronic Myeloid Leukaemia 5.1%
Hypertension 4.4%
Depression 3.8%
Prostate Cancer Metastatic 3.2%
Diabetes Mellitus 2.5%
Multiple Sclerosis 2.5%
Acute Myeloid Leukaemia 1.9%
Myelodysplastic Syndrome 1.9%
Nephrogenic Anaemia 1.9%
Antiplatelet Therapy 1.3%
Blood Cholesterol Abnormal 1.3%
Drug Use For Unknown Indication 1.3%
Immunodeficiency Common Variable 1.3%
Non-small Cell Lung Cancer 1.3%
Psychotic Disorder 1.3%
Type Iia Hyperlipidaemia 1.3%
5Q Minus Syndrome 0.6%
Pancreatitis 20.2%
Vomiting 14.3%
Nausea 9.5%
Weight Decreased 7.1%
Pancreatitis Acute 6.0%
Blood Glucose Increased 3.6%
Diarrhoea 3.6%
Platelet Count Decreased 3.6%
Pneumonia 3.6%
Vision Blurred 3.6%
White Blood Cell Count Decreased 3.6%
Anaemia 2.4%
Blood Glucose Decreased 2.4%
Death 2.4%
Hepatic Steatosis 2.4%
Hyperglycaemia 2.4%
Nasopharyngitis 2.4%
Pancytopenia 2.4%
Renal Failure 2.4%
Renal Failure Chronic 2.4%

Drug Data